Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of SCY-078 Combination Therapy with Voriconazole in Patients With Invasive Pulmonary Aspergillosis (SCYNERGIA)
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: SYNEOS HEALTH IVH UK LIMITED (FORMERLY INVENTIV HEALTH CLINICAL UK LTD),
- Phase: II
- Execution start: 23/09/2019
- End of execution: 30/04/2020
- PI: JUAN PASQUAU LIAÑO